Dissolve_D237_60_444_2500px

 

Angel-Scale Deals from Boston's Biotech Startups 

Why I'm Bullish on Biotech

After more than 60 angel investments it became obvious to me why I should dedicate all my efforts to investing in early stage biotech startups that met the following criteria:

  • Capable & committed academic founder
  • Strong patents
  • Technology that could be valuable to big strategic players
  • Angel-scale funding needs (no more than $ 6 million)
  • Platform technology with many use cases

Angel-Scale Biotech Is Here

Learn About the Trends 

Find out why I see so much promise in early-stage biotech  Why I Focus on Biotech. If this interests you consider signing up for the newsletter via the form at the bottom of the blog post. Thanks.

Sign Up!